Effect of a paraneoplastic cerebellar degeneration-associated neural protein on B-myb promoter activity

Neurobiology of Disease

Volumn 15, Issue 3, 2004, Pages 529-533

  Sakai, Koichiro ^a   Kitagawa, Yoko ^a   Saiki, Shinji ^a   Saiki, Misuzu ^a   Hirose, Genjiro ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

B myb; Cerebellar degeneration; Purkinje cell

Indexed keywords

ANIMAL CELL; ARTICLE; B MYB GENE; CELL CYCLE; CONTROLLED STUDY; GENE; GENETIC TRANSCRIPTION; NERVE CELL NECROSIS; NONHUMAN; PARANEOPLASTIC NEUROPATHY; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PURKINJE CELL;

ANIMALS; CELL CYCLE PROTEINS; CERCOPITHECUS AETHIOPS; CHROMOSOMAL PROTEINS, NON-HISTONE; COS CELLS; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; IMMUNOGLOBULIN G; NEOPLASM PROTEINS; NERVE DEGENERATION; NERVE TISSUE PROTEINS; PARANEOPLASTIC CEREBELLAR DEGENERATION; PROMOTER REGIONS (GENETICS); PURKINJE CELLS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 1842576577     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2003.11.003     Document Type: Article

References (20)

1. Albert M.L., Darnell J.C., Bender A., Francisco L.M., Bhardwaj N., Darnell R.B. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat. Med. 4:1998;1321-1324.
2. Bertram M.J., Berube N.G., Hang-Swanson X., Ran Q., Leung J.K., Bryce S., Spurgers K., Bick R.J., Baldini A., Ning Y., Clark L.J., Parkinson E.K., Barrett J.C., Smith J.R., Pereira-Smith O.M. Identification of a gene that reverses the immortal phenotype of a subset of cells and is a member of a novel family of transcription factor-like genes. Mol. Cell. Biol. 19:1999;1479-1485.
3. Borges L.F., Elliott P.J., Gill R., Iversen S.D., Iversen D.D. Selective extraction of small and large molecules from the cerebrospinal fluid by Purkinje neurons. Science. 228:1985;346-348.
4. Fathallah-Shaykh H., Wolf S., Wong E., Posner J.B., Furneaux H.M. Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. Proc. Natl. Acad. Sci. U. S. A. 88:1991;3451-3454.
5. Gendron T.F., Mealing G.A., Paris J., Lou A., Edwards A., Hou S.T., MacManus J.P., Hakim A.M., Morley P. Attenuation of neurotoxicity in cortical cultures and hippocampal slices from E2F1 knockout mice. J. Neurochem. 78:2001;316-324.
6. Greenlee J.E., Brashear H.R. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann. Neurol. 14:1983;609-613.
7. Hou S.T., Cowan E., Walker T., Ohan N., Dove M., Rasqinha I., MacManus J.P. The transcription factor E2F1 promotes dopamine-evoked neuronal apoptosis by a mechanism independent of transcriptional activation. J. Neurochem. 78:2001;287-297.
8. Leung J.K., Berube N., Venable S., Ahmed S., Timchenko N., Pereira-Smith O.M. MRG15 activates the B-myb promoter through formation of a nuclear complex with the retinoblastoma protein and the novel protein PAM14. J. Biol. Chem. 276:2001;39171-39178.
9. Liu D.X., Greene L.A. Regulation of neuronal survival and death by E2F-dependent gene repression and derepression. Neuron. 32:2001;425-438.
10. Liu D.X., Greene L.A. Neuronal apoptosis at the G1/S cell cycle checkpoint. Cell Tissue Res. 305:2001;217-228.
11. O'Hare M.J., Hou S.T., Morris E.J., Cregan S.P., Xu Q., Slack R.S., Park D.S. Induction and modulation of cerebellar granule neuron death by E2F-1. J. Biol. Chem. 275:2000;25358-25364.
12. Okano H.J., Park W.Y., Corradi J.P., Darnell R.B. The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival. Genes Dev. 13:1999;2087-2097.
13. Persengiev S.P., Li J., Poulin M.L., Kilpatrick D.L. E2F2 converts reversibly differentiated PC12 cells to an irreversible, neurotrophin-dependent state. Oncogene. 20:2001;5124-5131.
14. Sakai K., Mitchell D.J., Tsukamoto T., Steinman L. Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration. Ann. Neurol. 28:1990;692-698.
15. Sakai K., Ogasawara T., Hirose G., Jaeckle K.A., Greenlee J.E. Analysis of autoantibody binding to 52-kd paraneoplastic cerebellar degeneration- associated antigen expressed in recombinant proteins. Ann. Neurol. 33:1993;373-380.
16. Sakai K., Gofuku M., Kitagawa Y., Ogasawara T., Hirose G. Induction of anti-Purkinje cell antibodies in vivo by immunizing with a recombinant 52-kDa paraneoplastic cerebellar degeneration-associated protein. J. Neuroimmunol. 60:1995;135-141.
17. Sakai K., Shirakawa T., Li Y., Kitagawa Y., Hirose G. Interaction of a paraneoplastic cerebellar degeneration-associated neuronal protein with the nuclear helix-loop-helix leucine zipper protein MRG X. Mol. Cell. Neurosci. 19:2002;477-484.
18. Sakai K., Shirakawa T., Kitagawa Y., Li Y., Hirose G. Induction of cytotoxic T lymphocytes specific for paraneoplastic cerebellar degeneration-associated antigen in vivo by DNA immunization. J. Autoimmun. 17:2002;297-302.
19. Takanaga H., Mukai H., Shibata H., Toshimori M., Ono Y. PKN interacts with a paraneoplastic cerebellar degeneration-associated antigen, which is a potential transcription factor. Exp. Cell Res. 241:1998;363-372.
20. Tanaka K., Tanaka M., Onodera O., Igarashi S., Miyatake T., Tujji S. Passive transfer and active immunization with the recombinant leucine-zipper(Yo) protein as an attempt to establish an animal model of paraneoplastic cerebellar degeneration. J. Neurol. Sci. 127:1994;153-158.